key: cord-0890306-fqmxlee7
authors: Darbeheshti, Farzaneh; Mahdiannasser, Mojdeh; Uhal, Bruce D; Ogino, Shuji; Gupta, Sudhir; Rezaei, Nima
title: Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus
date: 2021-03-16
journal: Rev Med Virol
DOI: 10.1002/rmv.2234
sha: 80cdccded4a39994d5ef74d5daee6853787c6a3a
doc_id: 890306
cord_uid: fqmxlee7

The coronavirus disease (Covid‐19) pandemic is the most serious event of the year 2020, causing considerable global morbidity and mortality. The goal of this review is to provide a comprehensive summary of reported associations between inter‐individual immunogenic variants and disease susceptibility or symptoms caused by the coronavirus strains severe acute respiratory syndrome‐associated coronavirus, severe acute respiratory syndrome‐associated coronavirus‐2, and two of the main respiratory viruses, respiratory syncytial virus and influenza virus. The results suggest that the genetic background of the host could affect the levels of proinflammatory and anti‐inflammatory cytokines and might modulate the progression of Covid‐19 in affected patients. Notably, genetic variations in innate immune components such as toll‐like receptors and mannose‐binding lectin 2 play critical roles in the ability of the immune system to recognize coronavirus and initiate an early immune response to clear the virus and prevent the development of severe symptoms. This review provides promising clues related to the potential benefits of using immunotherapy and immune modulation for respiratory infectious disease treatment in a personalized manner.

immune response to clear the virus and prevent the development of severe symptoms. This review provides promising clues related to the potential benefits of using immunotherapy and immune modulation for respiratory infectious disease treatment in a personalized manner.

Covid-19, cytokine storm, genetic susceptibility, influenza virus, immune-related variants, RSV

The recent global coronavirus disease 2019 (Table 1 ).

Mannose-binding lection 2 (MBL2) is a soluble, Ca 2+ -dependent serum protein that is expressed primarily in the liver and secreted into the blood. MBL2 is a vital component of the innate immune response that provides a front line of host defense. 5 Genetic deficiency of MBL2 gene boosts susceptibility to viral and bacterial agents such as human immunodeficiency virus (HIV), influenza A and Neisseria meningitides. [6] [7] [8] 

The differences in the vulnerability of individuals to the coronavirus infections have been proposed to be linked to the key role of MBL2 in early host defense mechanisms, especially before producing specific antibodies. 9 Polymorphisms in the promoter (rs7096206, C/G) and exon 1 (rs1800450, G/A) have a significant association with SARS-CoV susceptibility. 10, 11 Moreover, the alleles associated with low expression of MBL2 are increasingly present in patients with other respiratory infectious diseases, such as invasive pneumococcal disease 12 and chronic obstructive pulmonary disease. 13,14

Dendritic cells (DCs) express pattern recognition receptors, such as CD209 and CLEC4M that directly recognize a wide range of microorganisms, for example, hepatitis C, HIV, SARS-CoV-1 coronavirus, and Ebola. Human CD209 and CLEC4M proteins are a C-type lectin, which comprises a Ca 2+ -dependent complementarity-determining region followed by a flexible neck region at the C-terminal domain, a transmembrane domain and a cytoplasmic N-terminal region.

The extended neck region in the extracellular domain is encoded by tandem repeats, which is involved in the recognition of pathogens. 15 

A genetic-risk association study revealed that homozygosity of the rs71179137 variant in CLEC4M tandem repeat plays a protective role for SARS-CoV infection. 16 However, this finding has not been approved by a case-control study in northern China. 17 The G allele of the rs4804803 polymorphism located on the CD209 promoter is associated with low promoter activity. 18 It has been suggested that the G allele could protect the lung from injury during the progression of SARS-CoV infection 19 and patients with the AA genotype had a 60% chance for developing severe symptoms. 18 In contrast, another study among 181 SARS patients and 172 controls reported that no genetic predisposition allele in the lectin genes cluster at 19p13.3 is involved in SARS-CoV-1 infection. 20 T A B L E 1 Summary of studies which reported the pathogen recognition-, presentation-and elimination-related genetic variants behind the susceptibility and vulnerability to coronavirus, respiratory syncytial virus and influenza in the respiratory tract, which results in inducing proinflammatory cytokines and interferons (IFNs) 23 (Figure 1 ).

Sequencing methods applied to young males without any underlying diseases from two independent families who showed the severe form of Covid-19 have revealed that rare mutations in TLR7 could be associated with severe symptoms and even death. 23 24 and some rare variants in IRF3 and IRF7 genes have been reported (Table 1) .

CD14 is a glycosylphosphatidylinositol-anchored receptor known to serve as a coreceptor for several TLRs both at the cell surface and in the endosomal compartment, which plays a unique role in initiating innate immunity through TLRs-mediated cytokine response. 25 A possible functional role of the CD14-c. 159T or no association with severe RSV disease. 30, 31 The rs5743836 SNP in the promoter of TLR9 was weakly associated with severe RSV, 32 and TLR9 rs352162 SNP was associated with the requirement for mechanical ventilation. Furthermore, rs352162 and rs187084 SNPs were associated with ICU admission. 33 As for TLR10, haplotype analysis demonstrated a weak yet significant association with RSV infection even though no single SNP was identified as the major polymorphism contributing to this demonstration. 32 

Investigation of TLR4 polymorphisms in individuals infected with the influenza virus revealed that these polymorphisms confer protection in the tonsils against Haemophilus influenzae. In addition, there was an association between the rs4986791 SNP and reduced risk of infection with H. influenzae. 34 

The human leukocyte antigens (HLA), which are critical components of the viral antigen presentation pathway, consist of the most polymorphic genes (Figures 2 and 3) . They have been shown in various reports to confer differential viral susceptibility and severity of disease. The associations between HLA genotypes and severity of infections extend broadly to several unrelated viruses.

In alleles showed a significant association with SARS-CoV infection. 35 In the Vietnamese population, a case-control study comprising SARS-CoV infected patients, healthy individuals without contact history and staff members who had contact with SARS-CoV infected patients, but had not developed the infection, revealed that HLA-DRB1*12 showed a significant positive association with developing SARS-CoV. 36 The tendency of patients with the HLA-DRB1*12 allele to develop infection has been supported in a large study from southern China. 37 The HLA-DRB4*01010101 allele is another variant in the Chinese population that was found to be significantly associated with genetic susceptibility to infection by F I G U R E 2 Antigen presentation by HLA class I proteins to CD8+ T cells (cytotoxic T cells). Proteins inside the cytosol of cells are degraded by the proteasome into peptide antigens. These peptides further pass through TAP into the ER, and will then bind to HLA proteins. Finally, antigen-bound receptors will translocate through the Golgi apparatus (not shown) to the plasma membrane and present the antigens to cytotoxic T cells. Associations between genetic variants in HLA class I genes with SARS-CoV-1 and -2 are shown in gray boxes. ER, endoplasmic reticulum; HLA, human leukocyte antigen; SARS-CoV, severe acute respiratory syndrome coronavirus; TAP, transporter associated with antigen processing DARBEHESHTI ET AL.

SARS-CoV. 38 Furthermore, in Taiwanese association studies, the HLA-B*4601 and HLA-Cw*0801 alleles were also found to associate with susceptibility to SARS-CoV infection. 39, 40 In studies on SARS- 

Cytokines are a group of small proteins, including IFNs, interleukins (ILs), chemokines, colony-stimulating factors and tumor necrosis factor-alpha (TNF-α) that are released by specific cells to regulate intercellular signaling (Figure 4) . In this section, the elements of inflammation in coronavirus, RSV and influenza infection will be discussed ( 71 Similarly, IL13 SNP 1112C/T (rs1800925) was associated with severe RSV in the study of Puthothu et al. 72 in contrary to the report of Choi et al. 70 The two IL13 SNPs rs20541 and rs1881457 were investigated for possible association with severe RSV. However, there was no significant association observed. 72 Other SNPs in ILs that were associated with RSV infection include the IL18 SNPs 133G/C (rs360721 74 ), and IL6 SNP -174G/C rs1800795, for which the GG and GC genotypes were associated with shorter hospital stay. 75 The IL10 SNP rs1800872 C allele was also associated with a higher risk of RSV-related wheeze reported by parents at the corrected age of 1. 76 Association of genetic diversity in other IL including IL19 rs2243191 and rs2243188, IL20 rs2981573, IL4R rs1805015 and IL7 rs2583762 SNPs, with post-lower respiratory tract infection (LRTI) recurrent wheeze caused by RSV has also been reported. 77 It is noteworthy that RSV has a gender-specific pattern of infection, as it is more predominant in boys. Investigation of possible genetic factors underlying gender specificity revealed that IL9 SNP rs2069885 confers disparate effects in boys and girls. The major allele of this SNP in boys was associated with higher susceptibility to severe forms of the disease, but reduced susceptibility in girls. On the other hand, haplotype analysis demonstrated that the TT haplotype was associated with the highest risk of bronchiolitis requiring hospitalization in girls. This haplotype includes the IL9 SNPs rs1799962 and rs2069885. 78

Variations in IL1A and IL1B genes are associated with susceptibility to pandemic A/H1N1 influenza virus. Allele T in IL1A rs17561 and allele C in IL1B rs1143627 are possibly associated with a higher risk of A (H1N1)pdm09 infection. 79 In the Iranian population, the AA genotype of IL1B rs16944 is associated with higher protection against influenza B infection. 57 However, another study stated that the decreased risk of infection is associated with the GG genotype of IL1B rs16944. 56 For IL17A SNP rs2275913, the lack of allele A is associated with a higher predisposition to Influenza virus. 57 The rs1554286 SNP in IL10 is significantly associated with the epiglottitis caused by invasive H. influenzae serotype B infection in immunized children. This SNP is in strong LD with two other polymorphisms within the promoter and the recessive genotype of this SNP is associated with epiglottitis. 80 The IL10 −1082A (rs1800870) and −592C (rs1800872) alleles were overrepresented in influenza patients and associated with a higher risk of being affected with severe infection. In the case of inflammatory conditions, the IL10 rs1800870 A allele is associated with lower levels of cytokine production, whereas the IL10 rs1800870 G allele leads to higher levels of cytokine production.

Individuals with the IL10 rs1800870 AA genotype are more susceptible to severe influenza virus infection. 81 Moreover, the GG and TG genotypes of the IL10 rs1800872 SNP were associated with severe influenza A/H3N2 disease in the Iranian population 56 while in another study, no association was observed between this IL10 SNP and severe influenza disease. 57 

Chemokines are small proteins that belong to the category of cell signaling molecules and induce chemotaxis in nearby cells. 82 allele. 89 It has been suggested that the rs1024611 variant could be involved in interindividual differences of host vulnerability to SARS- 

The CCL5 SNP rs2107538 is associated with RSV and RSV subtype Aassociated bronchiolitis. 33 Polymorphisms located within the promoter (−408G/A rs2107538; −28G/C rs2280788) and the first intron (In1.1T/C rs2280789) of CCL5 are in strong LD and it was demonstrated that a common combined genotype of these polymorphisms is associated with severe RSV infection. 92 In the category of chemokines, the CX3CR1 SNP rs3732378 (p.T280M; c.935C/T) variant was associated with RSV-related bronchiolitis, which is due to an interruption in the affinity of CX3CR1 to its ligand fractalkine. Carriers of the 280M allele were more prevalent among patients and individuals with genotypes containing this allele were more likely to be hospitalized due to RSV-related bronchiolitis. 93 CCR5 is the receptor of CCL5 and CCL3 that recruit various immune cells such as monocytes, T cells and basophils, and so on.

Regarding RSV infection, the −2459G (rs1799987) and −2554T

(rs2734648) variants of CCR5 are associated with severe RSVrelated bronchiolitis. 94 The effect of rs2734648 is not functionally clear, and the impact of rs1799987 is debating as it leads to both increased and decreased expression of CCR5. 75 Chemokine (C-X-C motif) ligand 9 (CXCL9)/induced by gamma IFN is a small cytokine of CXC chemokine and participates in several cellular and immune-related processes. 95 There is a significant association between CXCL9 rs2276886 and post-RSV LRTI recurrent wheeze. 77 3. severe influenza A virus, other studies suggest that homozygosity for this allele might predispose individuals to a mild form of influenza but not the severe form, 104 or suggest that this allele was not associated with pediatric influenza virus infection. 105 This SNP was not associated with seasonal influenza-related hospitalization. 106 On the other hand, allele C of the IFITM3 SNP rs12252 leads to a change of splice site sequence and was significantly overrepresented in hospitalized patients. Moreover, the minor IFITM3 CC genotype was linked to decreased restriction of influenza virus in vitro. In conclusion, IFITM3 is an important factor in morbidity and mortality of influenza virus infection. 107

Primary immunodeficiency (PID) patients are characterized by an impaired immune function that could result in susceptibility to severe infections. It is suggested that the frequency of severe Covid-19 is significantly higher in these patients. However, an opposite possibility is that PID patients are protected from Covid-19 due to suppression of cytokine storm, which is caused by a deficient inflammatory response in these patients. 108 Therefore, regarding the two mentioned scenarios in the introduction, PID could affect in- 

The attention given to the roles of interindividual immunogenic variants in infectious diseases has become more remarkable over the 

Genetic predisposition models to COVID-19 infection

Covid-19: time for a paradigm change

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19 with different severities: a multicenter study of clinical features

Role of the mannose-binding lectin in innate immunity

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

Human mannose-binding protein functions as an opsonin for influenza A viruses

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease

Coronavirus as a possible cause of severe acute respiratory syndrome

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection

Association between mannosebinding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection

MBL genotype and risk of invasive pneumococcal disease: a case-control study

Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections

Mannan-binding lectin (MBL) serum levels in a healthy adult population: gender differences in prevalence of MBL deficiency

The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region

Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection

Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection

DC-SIGN) −336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese

Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity

Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Type I and type III interferons-induction, signaling, evasion, and application to combat COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

CD14: biology and role in the pathogenesis of disease

High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus

Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease

Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children

TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease

Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children

Common human toll-like receptor 4 polymorphisms-role in susceptibility to respiratory syncytial virus infection and functional immunological relevance

Polymorphisms of toll like receptors in the genetics of severe RSV associated diseases

Association between single nucleotide polymorphisms in TLR4, TLR2, TLR9, VDR, NOS2 and CCL5 genes with acute viral bronchiolitis

Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to Streptococcus pyogenes and Haemophilus influenzae

Association of human-leukocyteantigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome

Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population

Lack of association between HLA-A,-B and-DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China

Immunogenetics in SARS: a casecontrol study

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003

Human leukocyte antigen susceptibility map for SARS-CoV-2

Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19

Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection

Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome

A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection

Aberrant pathogenic GM-CSF + T cells and inflammatory CD14 + CD16 + monocytes in severe pulmonary syndrome patients of a new coronavirus

Interferons and viral infections

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

The interferon gamma gene polymorphism ?874A/T is associated with severe acute respiratory syndrome

Cytokine gene polymorphisms in patients infected with hepatitis B virus

Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese

A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes

Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes

IFN-gamma CA microsatellite polymorphism is associated with susceptibility to respiratory syncytial virus Infection and severity

Seasonal influenza A/H3N2 virus infection and IL-1beta, IL-10, IL-17, and IL-28 polymorphisms in Iranian population

Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population

Interleukin-1 and neuronal injury

Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms

IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese

The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Association of tumor necrosis factor alpha -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis

Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS)

IL6 gene-wide haplotype is associated with susceptibility to acute lung injury

Association of IL-10 (-819T/C,-592A/ C and-1082A/G) and IL-6-174G/C gene polymorphism and the risk of pneumonia-induced sepsis

IL-4: role in disease and regulation of production

The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis

IL1RL1 gene variants and nasopharyngeal IL1RL-a levels are associated with severe RSV bronchiolitis: a multicenter cohort study

A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children

Assessment of genetic associations between common single nucleotide polymorphisms in RIG-I-like receptor and IL-4 signaling genes and severe respiratory syncytial virus infection in children: a candidate gene case-control study

Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes

Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms

Interleukin (IL)-18 polymorphism 133C/G is associated with severe respiratory syncytial virus infection

Human genetic factors and respiratory syncytial virus disease severity

Genetic predisposition of RSV infection-related respiratory morbidity in preterm 14 of 16

IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis

Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls

Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus

Association between single-nucleotide polymorphisms inMal/TIRAP and interleukin-10 genes and susceptibility to invasive Haemophilus influenzae serotype b infection in immunized children

Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09

Chemokine signaling in development and disease

Chemokine receptors: multifaceted therapeutic targets

Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation

The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese

Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection

Chemokine up-regulation in sars-coronavirus-infected, monocyte-derived human dendritic cells

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study

Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection

Genomewide association study of severe covid-19 with respiratory failure

RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis

T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis

Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus

CXCL10, CXCL11/ CXCR3 axis for immune activation-a target for novel cancer therapy

Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes

Roles of TNF-α gene polymorphisms in the occurrence and progress of SARS-Cov infection: a casecontrol study

Association of TNFRSF1B promoter polymorphisms with human disease: further studies examining Tregulatory cells are required

Significance of the Myxovirus resistance A (MxA) gene-123C> a single-nucleotide polymorphism in suppressed interferon β induction of severe acute respiratory syndrome coronavirus infection

Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population

Differential transcriptional expression of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment

Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study

Antiviral protection by IFITM3 in vivo

IFITM3 and severe influenza virus infection. No evidence of genetic association

Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection

Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission

IFITM3 restricts the morbidity and mortality associated with influenza

Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor?

COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Genetic mechanisms of critical illness in COVID-19

Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel

Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency

Coronavirus disease 2019 in patients with inborn errors of immunity: an international study

Case report: systemic inflammatory response and fast recovery in a pediatric patient with COVID-19

Presence of genetic variants among young men with severe COVID-19

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis

Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus

The authors declare that they have no conflict of interests. 

https://orcid.org/0000-0002-4957-9004Nima Rezaei https://orcid.org/0000-0002-3836-1827